323 related articles for article (PubMed ID: 27038460)
1. Mouse Models for Immune-Mediated Platelet Destruction or Immune Thrombocytopenia (ITP).
Neschadim A; Branch DR
Curr Protoc Immunol; 2016 Apr; 113():15.30.1-15.30.13. PubMed ID: 27038460
[TBL] [Abstract][Full Text] [Related]
2. Mouse models of autoimmune diseases: immune thrombocytopenia.
Neschadim A; Branch DR
Curr Pharm Des; 2015; 21(18):2487-97. PubMed ID: 25777762
[TBL] [Abstract][Full Text] [Related]
3. Novel Murine Model of Immune Thrombocytopaenia through Immunized CD41 Knockout Mice.
Li X; Wang SW; Feng Q; Hou Y; Lu N; Ma CH; Gao CJ; Hou M; Peng J
Thromb Haemost; 2019 Mar; 119(3):377-383. PubMed ID: 30630213
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia.
Guo L; Kapur R; Aslam R; Hunt K; Hou Y; Zufferey A; Speck ER; Rondina MT; Lazarus AH; Ni H; Semple JW
Scand J Immunol; 2018 Jul; 88(1):e12678. PubMed ID: 29855061
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody against integrin α
Zeng DF; Chen F; Wang S; Chen SL; Xu Y; Shen MQ; Du CH; Wang C; Kong PY; Cheng TM; Su YP; Wang JP
J Thromb Haemost; 2018 Sep; 16(9):1843-1856. PubMed ID: 29953749
[TBL] [Abstract][Full Text] [Related]
6. Cytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on the mouse strain.
Leontyev D; Neschadim A; Branch DR
Transfusion; 2014 Nov; 54(11):2871-9. PubMed ID: 24826802
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia.
Teeling JL; Jansen-Hendriks T; Kuijpers TW; de Haas M; van de Winkel JG; Hack CE; Bleeker WK
Blood; 2001 Aug; 98(4):1095-9. PubMed ID: 11493456
[TBL] [Abstract][Full Text] [Related]
8. A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs?
LeVine DN; Birkenheuer AJ; Brooks MB; Nordone SK; Bellinger DA; Jones SL; Fischer TH; Oglesbee SE; Frey K; Brinson NS; Peters AP; Marr HS; Motsinger-Reif A; Gudbrandsdottir S; Bussel JB; Key NS
Br J Haematol; 2014 Oct; 167(1):110-20. PubMed ID: 25039744
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway.
Crow AR; Yu H; Han D; Lazarus AH
PLoS One; 2013; 8(8):e71882. PubMed ID: 23940791
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
[TBL] [Abstract][Full Text] [Related]
11. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.
Bakchoul T; Sachs UJ
Hamostaseologie; 2016 Aug; 36(3):187-94. PubMed ID: 25982994
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of IVIG action in immune thrombocytopenic purpura.
Hansen RJ; Balthasar JP
Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
[TBL] [Abstract][Full Text] [Related]
13. The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura.
Chan H; Moore JC; Finch CN; Warkentin TE; Kelton JG
Br J Haematol; 2003 Sep; 122(5):818-24. PubMed ID: 12930395
[TBL] [Abstract][Full Text] [Related]
14. The neonatal Fc receptor (FcRn) is not required for IVIg or anti-CD44 monoclonal antibody-mediated amelioration of murine immune thrombocytopenia.
Crow AR; Suppa SJ; Chen X; Mott PJ; Lazarus AH
Blood; 2011 Dec; 118(24):6403-6. PubMed ID: 22001393
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside.
Crow AR; Lazarus AH
Semin Hematol; 2016 Apr; 53 Suppl 1():S20-2. PubMed ID: 27312158
[TBL] [Abstract][Full Text] [Related]
16. Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disorders.
Clofent-Sanchez G; Laroche-Trainean J; Lucas S; Rispal P; Pellegrin JL; Nurden P; Nurden A
Hum Antibodies; 1997; 8(2):50-9. PubMed ID: 9289388
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia.
Hansen RJ; Balthasar JP
J Pharm Sci; 2003 Jun; 92(6):1206-15. PubMed ID: 12761810
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
Song S; Crow AR; Freedman J; Lazarus AH
Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021
[TBL] [Abstract][Full Text] [Related]
20. Vincristine-loaded platelets coated with anti-CD41 mAbs: a new macrophage targeting proposal for the treatment of immune thrombocytopenia.
Xu P; Jiang Y; Zuo H; Liu X; Xia T; Zhou R; Chen B; Ouyang J
Biomater Sci; 2019 Nov; 7(11):4568-4577. PubMed ID: 31414106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
